Project Grant HT94252510307
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded Vanderbilt University Medical Center (VUMC) a $2,192,538 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TOXICANT-MEDIATED PULMONARY HYPERTENSION IN SOUTHWEST ASIA VETERANS," will fund advanced biomedical research focused on transforming healthcare for military service members and the broader public. The project will investigate innovative...
The Department of the Army Medical Command awarded a $782,955.27 Project Grant to Vanderbilt University Medical Center on September 15, 2022, with a completion date of September 14, 2025. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to modulate lung and bone microenvironments to treat breast cancer metastases. The program aims to transform military and public health through innovative biomedical research solutions for battlefield...
The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $1,310,914 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on monitoring peripheral immunity to chemotherapy and immunotherapy in breast cancer. The 3-year award, which began on February 1, 2024, aims to advance the understanding of biomarkers and identify novel therapies for breast cancer treatment. As a leading academic medical center with...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
The Department of the Army Medical Command awarded Vanderbilt University a $1.6 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research into Modulation of Lung and Bone Microenvironments to Treat Breast Metastases. The three-year award beginning September 15, 2022 will fund investigation into medical solutions for breast cancer that has metastasized to the lungs and bones. As part of the Military Medical Research and Development...
Vanderbilt University Medical Center was awarded a $1,727,296 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from February 15, 2022 to February 14, 2025 to assess the role of intracellular parathyroid hormone-related protein signaling in mechanisms of tumor dormancy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
The University of Arizona was awarded a $2,611,139 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to support research on Novel Therapeutics for Pulmonary Hypertension. The four-year award beginning May 1, 2022 will fund the development of new drug therapies to treat pulmonary hypertension, a condition affecting blood pressure in the lungs that can impact military service members. As part of the work,...
The Department of the Army Medical Command awarded a $700,000 Cooperative Agreement to Vanderbilt University Medical Center (VUMC) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from September 15, 2024 to September 14, 2026, supports the KIDNEY CANCER CLINICAL TRIALS CONSORTIUM project to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public....
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...